Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes

The Journal of Prevention of Alzheimer's Disease · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles